Pay in 4 interest-free payments of $5.17 Learn more
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
Contraindications Tirzepatide, whether compounded or brand-name, should not be used by individuals with a personal or family history of medullary thyroid carcinoma, Multiple Endocrine Neoplasia syndrome type 2, severe gastroparesis or gastrointestinal disease, or during pregnancy
IGF-1 promotes protein synthesis, enhances glucose uptake in skeletal muscle, stimulates lipolysis in adipose tissue, and plays crucial roles in tissue repair and regeneration
It is prohibited by the World Anti-Doping Agency for any athlete subject to drug testing
Aesthetic clinics
Weight loss results vary by individual, but in clinical studies, people taking GLP-1 Treatments, Semaglutide or Tirzepatide for weight loss have lost, on average, 10-15% of their body weight over a 6-month to 1-year period
